Abstract

Phox homology (PX) domains are membrane interacting domains that bind to phosphatidylinositol phospholipids or phosphoinositides, markers of organelle identity in the endocytic system. Although many PX domains bind the canonical endosome-enriched lipid PtdIns3P, others interact with alternative phosphoinositides, and a precise understanding of how these specificities arise has remained elusive. Here we systematically screen all human PX domains for their phospholipid preferences using liposome binding assays, biolayer interferometry and isothermal titration calorimetry. These analyses define four distinct classes of human PX domains that either bind specifically to PtdIns3P, non-specifically to various di- and tri-phosphorylated phosphoinositides, bind both PtdIns3P and other phosphoinositides, or associate with none of the lipids tested. A comprehensive evaluation of PX domain structures reveals two distinct binding sites that explain these specificities, providing a basis for defining and predicting the functional membrane interactions of the entire PX domain protein family.

Phox homology (PX) domains are membrane interacting domains that bind to various lipids. Here authors screen all human PX domains systematically for their phospholipid preferences and define four classes and provide the basis for defining and predicting functional PX-membrane interactions.

Details

Title
Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities
Author
Chandra Mintu 1 ; Chin, Yanni K-Y 1 ; Mas, Caroline 2 ; Ryan, Feathers J 3 ; Blessy, Paul 1 ; Datta Sanchari 3 ; Chen Kai-En 1   VIAFID ORCID Logo  ; Jia Xinying 4   VIAFID ORCID Logo  ; Yang, Zhe 5 ; Norwood, Suzanne J 1 ; Mohanty Biswaranjan 6 ; Bugarcic, Andrea 1 ; Teasdale, Rohan D 7 ; Mike, Henne W 3 ; Mobli Mehdi 4   VIAFID ORCID Logo  ; Collins, Brett M 1 

 The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Integrated Structural Biology Grenoble, Grenoble, France (GRID:grid.1003.2) 
 University of Texas Southwestern Medical Center, Department of Cell Biology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 The University of Queensland, Centre for Advanced Imaging and School of Chemistry and Molecular Biology, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 The University of Queensland, School of Biomedical Sciences, Faculty of Medicine, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 Monash University, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Parkville, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The University of Queensland, School of Biomedical Sciences, Faculty of Medicine, St. Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2203124916
Copyright
© Crown 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.